Antengene To Present One Oral and Four Abstracts at ASCO 2024

/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...

Related Keywords

China ,Chicago ,Illinois ,United States ,Shanghai ,Taiwan ,Macau ,South Korea ,Hong Kong ,Singapore ,Australia ,Beijing ,Mccormick Place ,American ,Asia Pacific ,Peter Qian ,Antengene Corporation Limited ,Prnewswire Antengene Corporation Limited ,Mccormick Place Convention Center ,Hong Kong Stock Exchange ,Company Annual ,Antengene Corporation ,American Society Of Clinical Oncology ,Oral Presentation ,Corporation Limited ,Clinical Oncology ,Annual Meeting ,Clinical Science Symposium ,Stronger Together ,Novel Combinations Across ,Gynecologic Cancer ,Central Daylight Time ,Beijing Time ,Poster Presentations ,Developmental Therapeutics ,Bayesian Optimal Interval ,Molecularly Targeted Agents ,Hematologic Malignancies ,Chronic Lymphocytic ,Journal Publication ,Publication Only ,Patients Beyond ,Taiwan China ,Hong Kong China ,Macau China ,Annual Report ,Hong Kong Stock ,